Lilly’s oral GLP-1 drug nears global filing
Lilly’s oral GLP-1 pill helped patients lose 22 pounds and lower A1C in a Phase 3 trial, with global filings planned this year.
Eli Lilly
Lilly to expand collaboration with Purdue University
Will include a planned investment up to a $250 million to accelerate pharmaceutical innovation.
LillyDirect platform expands to improve access to Alzheimer's care
Eli Lilly and Company enhances digital healthcare offerings to address delays in diagnosis and treatment.